These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1589911)

  • 1. Grading and prognostic significance of urologic carcinomas.
    Helpap B
    Urol Int; 1992; 48(3):245-57. PubMed ID: 1589911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor markers in the histopathology of urologic tumors].
    Hofstädter F
    Urologe A; 1987 Jan; 26(1):2-6. PubMed ID: 3576859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytology of the urinary tract. A demonstration of indications and cytologic findings in various disease pictures].
    Fladerer HP
    Fortschr Med; 1984 Sep; 102(33):815-8. PubMed ID: 6479823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urologic tumors in the Federal Republic of Germany: data on 56,013 cases from hospital cancer registries.
    Fischer CG; Waechter W; Kraus S; Fuentecilla Perez E; Weidner W; Dudeck J
    Cancer; 1998 Feb; 82(4):775-83. PubMed ID: 9477112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates in Histologic Grading of Urologic Neoplasms.
    Rice-Stitt T; Valencia-Guerrero A; Cornejo KM; Wu CL
    Arch Pathol Lab Med; 2020 Mar; 144(3):335-343. PubMed ID: 32101058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sarcomatoid carcinoma of the urinary tract: clinical analysis of 16 cases].
    Zhou C; Xie LP; Zheng XY
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):634-5. PubMed ID: 22325229
    [No Abstract]   [Full Text] [Related]  

  • 8. Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma.
    Rojas CP; Castle SM; Llanos CA; Santos Cortes JA; Bird V; Rodriguez S; Reis IM; Zhao W; Gomez-Fernandez C; Leveillee RJ; Jorda M
    Urol Oncol; 2013 Nov; 31(8):1696-700. PubMed ID: 22819696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
    Saito K; Kihara K
    Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cultivation of urologic and male genital tumor cells].
    Liu CJ; Wang ZQ; Chang JW; Zhang X; Liu XB; Liu CN; Ma TX
    Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):178-80. PubMed ID: 3743344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyruvate kinase type tumor M2 in urological malignancies.
    Hegele A; Varga Z; Kosche B; Stief T; Heidenreich A; Hofmann R
    Urol Int; 2003; 70(1):55-8. PubMed ID: 12566817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the human tumor cloning assay for urologic malignancies with special emphasis on bladder cancer.
    Dittrich C; Schmidbauer CP; Havelec L; Lenzhofer R; Breyer S; Porpaczy P; Moser K
    Oncology; 1986; 43(1):40-5. PubMed ID: 3941801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility and reliability of tumor grading in urological neoplasms.
    Engers R
    World J Urol; 2007 Dec; 25(6):595-605. PubMed ID: 17828603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.
    Soma O; Hatakeyama S; Okamoto T; Fujita N; Hamano I; Tanaka T; Momota M; Yoneyama T; Yamamoto H; Imai A; Yoneyama T; Hashimoto Y; Yoshikawa K; Kawaguchi T; Saitoh H; Nakaji S; Suzuki T; Ohyama C
    Med Oncol; 2019 Sep; 36(10):88. PubMed ID: 31520152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear cell carcinoma of the lower urinary tract in a male patient. Presentation and update on histogenesis and management.
    Tyritzis SI; Anastasiou I; Petrolekas A; Alevizopoulos A; Mitropoulos D; Constantinides CA
    Pathol Int; 2009 Aug; 59(8):595-7. PubMed ID: 19627546
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative light microscopy in urological oncology.
    van der Poel HG; Schaafsma HE; Vooijs GP; Debruyne FM; Schalken JA
    J Urol; 1992 Jul; 148(1):1-13. PubMed ID: 1613843
    [No Abstract]   [Full Text] [Related]  

  • 18. Grading of upper urinary tract transitional cell carcinoma by computed DNA content and p53 expression.
    Minimo C; Tawfiek ER; Bagley DH; McCue PA; Bibbo M
    Urology; 1997 Dec; 50(6):869-74. PubMed ID: 9426716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
    Tonyali S; Yazici S
    Int Urol Nephrol; 2016 May; 48(5):671-80. PubMed ID: 26843415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
    Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
    Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.